[Assessment of reasons for XXXX treatment change].

@entity1 @entity2182 @entity34
OBJECTIVES: although efficacious, some @entity1 do not respond optimally to @entity2182 ( @entity2182 ) treatment. The objective of this study was to identify the reasons why some @entity1 do not respond and to look for reasons for changes in treatment and @entity1 satisfaction with the new treatment. MATERIALS AND METHODS: epidemiological, cross-sectional, non-interventional study to determine the reasons for @entity2182 treatment switching and satisfaction with such @entity2182 treatment switch. @entity2182 @entity1 ( @entity2182 -V8>= 8), 18 years or more, who had modified their treatment during the previous 3-4 months, were recruited. Demographic data, symptoms, previous, current and concomitant treatments, reasons for treatment switch, clinical global impression (CGI) on disease severity and symptom improvement, Morinsky Green questionnaire, satisfaction with treatment, treatment preference and @entity34 ( @entity34 ) were compared. RESULTS: out of 3,365 successive @entity1 , 2,038 (61%) were eligible (61.1  11.2 years; 77% @entity1 ). The physician decided to switch in 69% of the cases and 31% of @entity1 asked for a change in treatment. Reasons for switching were lack of clinical benefit (60%), side effects (24%), @entity1 ' request (8%), non-compliance (6%) and other (2%). 52% of @entity1 complied with new treatment. According to the CGI, 65.4% showed improvement with respect to their previous treatment. 60% were quite/very satisfied with current treatment, 91% preferred it to their previous treatment and 93% reported that their symptoms had improved. CONCLUSIONS: the lack of clinical benefit is the main reason for changing @entity2182 treatment. Most of the @entity1 that switched prefer their new treatment.
